Drug Shortage Report for TARO-DASATINIB
| Report ID | 173713 |
| Drug Identification Number | 02499304 |
| Brand name | TARO-DASATINIB |
| Common or Proper name | DASATINIB |
| Company Name | TARO PHARMACEUTICALS INC |
| Market Status | MARKETED |
| Active Ingredient(s) | DASATINIB |
| Strength(s) | 50MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 60 |
| ATC code | L01EA |
| ATC description | |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2022-06-01 |
| Estimated end date | 2023-10-06 |
| Actual end date | 2023-09-26 |
| Shortage status | Resolved |
| Updated date | 2023-10-25 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 130 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v28 | 2023-10-25 | French | Compare |
| v27 | 2023-10-25 | English | Compare |
| v26 | 2023-09-22 | French | Compare |
| v25 | 2023-09-22 | English | Compare |
| v24 | 2023-08-16 | French | Compare |
| v23 | 2023-08-16 | English | Compare |
| v22 | 2023-07-18 | French | Compare |
| v21 | 2023-07-18 | English | Compare |
| v20 | 2023-04-10 | French | Compare |
| v19 | 2023-04-10 | English | Compare |
| v18 | 2023-03-24 | French | Compare |
| v17 | 2023-03-24 | English | Compare |
| v16 | 2023-03-10 | French | Compare |
| v15 | 2023-03-10 | English | Compare |
| v14 | 2023-02-01 | French | Compare |
| v13 | 2023-02-01 | English | Compare |
| v12 | 2023-01-19 | French | Compare |
| v11 | 2023-01-19 | English | Compare |
| v10 | 2023-01-10 | French | Compare |
| v9 | 2023-01-10 | English | Compare |